Compare CRIS & RUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRIS | RUBI |
|---|---|---|
| Founded | 2000 | 2022 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.7M |
| IPO Year | 2000 | 2022 |
| Metric | CRIS | RUBI |
|---|---|---|
| Price | $0.64 | $0.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $42.67 | N/A |
| AVG Volume (30 Days) | 160.7K | ★ 454.7K |
| Earning Date | 11-05-2026 | 05-06-2020 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.19 |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.34 | $0.13 |
| 52 Week High | $3,360.00 | $6.69 |
| Indicator | CRIS | RUBI |
|---|---|---|
| Relative Strength Index (RSI) | 19.38 | 14.16 |
| Support Level | $0.34 | $0.38 |
| Resistance Level | $5.50 | $0.68 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | 1.34 | -0.05 |
| Stochastic Oscillator | 6.85 | 0.15 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Rubico Inc is an international provider of crude oil transportation services. The Company is engaged in the ownership and operation of a fleet of tanker vessels designed for enhanced fuel efficiency and reduced greenhouse gas emissions, incorporating environmentally friendly technologies.